"Cleveland Clinic is one of the largest and most respected hospitals in the country. Our mission is to provide better care of the sick, investigation into their problems, and further education of those who serve. Learn more about our leadership, vision, values and model of healthcare. Every life deserves world class care. Call or visit our website for appointment information."

During the past decade, Cleveland Clinic Cancer Center/Fairview Hospital conducted 101 clinical trials. In the 10-year time frame, 101 clinical trials started and 121 clinical trials were completed, i.e. on average, 119.8% percent of trials that started reached the finish line to date. In the past 5 years, 37 clinical trials started and 67 clinical trials were completed. i.e. 181.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cleveland Clinic Cancer Center/Fairview Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 89 trials, followed by "SWOG Cancer Research Network" with 31 trials sponsored, "Gynecologic Oncology Group" with 24 trials sponsored, "NRG Oncology" with 20 trials sponsored and "Radiation Therapy Oncology Group" with 20 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cleveland Clinic Cancer Center/Fairview Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 126 trials as a collaborator, "NRG Oncology" with 64 trials as a collaborator, "Cancer and Leukemia Group B" with 8 trials as a collaborator, "Gynecologic Oncology Group" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 6 trials as a collaborator. Other collaborators include 46 different institutions and companies that were collaborators in the rest 33 trials.

According to Clinical.Site data, the most researched conditions in "Cleveland Clinic Cancer Center/Fairview Hospital" are "Recurrent Ovarian Carcinoma" (23 trials), "Recurrent Fallopian Tube Carcinoma" (18 trials), "Recurrent Primary Peritoneal Carcinoma" (17 trials), "Breast Cancer" (14 trials) and "Ovarian Endometrioid Adenocarcinoma" (14 trials). Many other conditions were trialed in "Cleveland Clinic Cancer Center/Fairview Hospital" in a lesser frequency.

Most popular intervention types in "Cleveland Clinic Cancer Center/Fairview Hospital" are "Drug" (183 trials), "Other" (130 trials), "Biological" (84 trials), "Radiation" (60 trials) and "Procedure" (40 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (78 trials), "Quality-of-Life Assessment" (59 trials), "Paclitaxel" (48 trials), "Carboplatin" (37 trials) and "Cisplatin" (30 trials). Other intervention names were less common.

The vast majority of trials in "Cleveland Clinic Cancer Center/Fairview Hospital" are 109 trials for "All" genders, 101 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are NaN active trials in "Cleveland Clinic Cancer Center/Fairview Hospital". undefined are not yet recruiting, 37 are recruiting, 88 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 83 completed trials in Cleveland Clinic Cancer Center/Fairview Hospital, 4 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Cleveland Clinic Cancer Center/Fairview Hospital, 10 "Phase 1" clinical trials were conducted, 102 "Phase 2" clinical trials and 125 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 9 trials that are defined as “Not Applicable".